Who are Argá Medtech's investors?

Argá Medtech's investors include Advent Life Sciences, High Tech Gruenderfonds, Earlybird Venture Capital, Gilde Healthcare, HTGF.

Argá Medtech

6 known investors

Find your way into Argá Medtech

Paths you didn't know you had: your email and LinkedIn already hold routes to the Argá Medtech team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Argá Medtech is developing a non-thermal cardiac ablation system based on a proprietary Pulsed Field Ablation (PFA) technology using sine wave energy and a proprietary catheter to treat atrial fibrillation and other heart arrhythmias. The system targets electrophysiology and interventional cardiology, aiming to improve the safety, speed, and long-term outcomes of cardiac ablation.

Hardware Healthtech Medical Devices

Investors · 6

Advent Life Scienceslisted by Advent Life SciencesLondon

How we know: Advent Life Sciences's portfolio page · funding news · bioalps.org · open dataset · 5k.vc investor directory · Not right? Tell us

High Tech Gruenderfondslisted by High Tech GruenderfondsBonn · $880K – $33M

How we know: High Tech Gruenderfonds's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Earlybird Venture CapitalreportedBerlin · $540K – $12M

How we know: gildehealthcare.com · Not right? Tell us

Gilde HealthcarereportedUtrecht · $1.1M – $55M

How we know: funding news · bioalps.org · Not right? Tell us

HTGFreportedBonn · $1.1M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Also in the syndicate · 1

Earlybird Healthlead

Funding

SEC filings, press & company announcements

Undisclosed amountSeries BFeb 2024 · 3 sources
Advent Life Sciences (lead), Earlybird Health (lead), Gilde Healthcare (lead), Earlybird Venture Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Argá Medtech Reports 94% Lesion Durability and Strong Safety Profile in First-in-Human BURST-AF Trial of Single-Catheter PFA Systemfinance.yahoo.com · Feb 2026

Frequently asked questions

What does Argá Medtech do?: Argá Medtech is developing a non-thermal cardiac ablation system based on a proprietary Pulsed Field Ablation (PFA) technology using sine wave energy and a proprietary catheter to treat atrial fibrillation and other heart arrhythmias. The system targets electrophysiology and interventional cardiology, aiming to improve the safety, speed, and long-term outcomes of cardiac ablation.
Who are Argá Medtech's investors?: Argá Medtech's investors include Advent Life Sciences, High Tech Gruenderfonds, Earlybird Venture Capital, Gilde Healthcare, HTGF.